illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. ShockWave Medical
Company logo

ShockWave Medical | Sustainability Performance

https://shockwavemedical.com

Develops medical devices for cardiovascular applications, specializing in intravascular lithotripsy for treating arterial diseases.

2009

United States

1,001 - 5,000 employees

Medical Device

$500M - 1B in revenue

$25M - 100M in profitability

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#4976
Overallⓘ
#1073
in United Statesⓘ
#86
in Medical Deviceⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

88 out of 169

Overview
Environmental
Energy consumption
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Penumbra

United States, Health Care, Medical Device


Company logo
Boston Scientific

United States, Health Care, Medical Device


Company logo
Inspire Medical Systems

United States, Health Care, Medical Device

Renewable energy ⓘProportion of the company's total electricity consumption sourced from renewable sources, expressed as a percentage.
100%2022
Leading
Market cap ⓘTotal market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.
12.8B$, 2024
Revenue ⓘTotal revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.
730.0M$, 2023▼33% YoY
R&D intensity ⓘResearch and development expenditure expressed as a percentage of revenue, reflecting the company's relative investment in innovation.
19.86%2023

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Shiseido faced criticism for cosmetic animal testing practices.
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

Total sustainability employees

4-6

ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.


    Available in
    Scale package

    Access
  • Email

  • Email